Correlation Between Isofol Medical and AroCell AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Isofol Medical and AroCell AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Isofol Medical and AroCell AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Isofol Medical AB and AroCell AB, you can compare the effects of market volatilities on Isofol Medical and AroCell AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Isofol Medical with a short position of AroCell AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Isofol Medical and AroCell AB.

Diversification Opportunities for Isofol Medical and AroCell AB

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Isofol and AroCell is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Isofol Medical AB and AroCell AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AroCell AB and Isofol Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Isofol Medical AB are associated (or correlated) with AroCell AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AroCell AB has no effect on the direction of Isofol Medical i.e., Isofol Medical and AroCell AB go up and down completely randomly.

Pair Corralation between Isofol Medical and AroCell AB

Assuming the 90 days trading horizon Isofol Medical AB is expected to generate 2.07 times more return on investment than AroCell AB. However, Isofol Medical is 2.07 times more volatile than AroCell AB. It trades about 0.06 of its potential returns per unit of risk. AroCell AB is currently generating about 0.0 per unit of risk. If you would invest  70.00  in Isofol Medical AB on September 13, 2024 and sell it today you would earn a total of  154.00  from holding Isofol Medical AB or generate 220.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Isofol Medical AB  vs.  AroCell AB

 Performance 
       Timeline  
Isofol Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
AroCell AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AroCell AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Isofol Medical and AroCell AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Isofol Medical and AroCell AB

The main advantage of trading using opposite Isofol Medical and AroCell AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Isofol Medical position performs unexpectedly, AroCell AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AroCell AB will offset losses from the drop in AroCell AB's long position.
The idea behind Isofol Medical AB and AroCell AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios